Type
. 25 years of MDT: a caveat. Leprosy review [Internet]. 2004;75(4):406. Available from: https://leprosyreview.org/article/75/4/40-6046
Type
. Leprosy elimination campaign (LEC) in Hodeidah Province, Republic of Yemen, 1997-1998: results and treatment outcome. Leprosy review [Internet]. 2004;75(4):405. Available from: https://leprosyreview.org/article/75/4/40-5405
Type
. Death caused by strongyloides hyperinfection in a leprosy patient on treatment for a type II leprosy reaction. Leprosy review [Internet]. 2004;75(4):398-403. Available from: https://leprosyreview.org/article/75/4/39-8403
Type
. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP. Leprosy review [Internet]. 2004;75(4):376-88. Available from: https://leprosyreview.org/article/75/4/37-6388
Type
. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions. Leprosy review [Internet]. 2004;75(4):310-26. Available from: https://leprosyreview.org/article/75/4/31-0326
Type
. Leprosy in Africa: a contrasted picture. Leprosy review [Internet]. 2004;75(4):306-9. Available from: https://leprosyreview.org/article/75/4/30-6309
Type
. Hidden leprosy--who is hiding from whom?. Leprosy review [Internet]. 2004;75(4):303-5. Available from: https://leprosyreview.org/article/75/4/30-3305
Type
. The impact of hand dominance and ulnar and median nerve impairment on strength and basic daily activities. Journal of hand therapy : official journal of the American Society of Hand Therapists. 2005;18(1):40-5.
Type
. [Patient with rhinorrea, destruction of nasal cartilage and hypochronic lesions of the skin]. Acta otorrinolaringologica espanola [Internet]. 2004;55(10):491-4. Available from: http://acta.otorrinolaringol.esp.medynet.com/textocompleto/acta_ing10/8.pdf
Type
. Dapsone hypersensitivity syndrome in an adolescent during treatment during of leprosy. Revista do Instituto de Medicina Tropical de Sao Paulo. 2004;46(6):331-4.